David M. Foureau, PhD of Levine Cancer Institute gives an overview of his abstract, Peripheral Immune Profile and Minimal Residual Disease (MRD) Burden Following Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM), that was presented at the 58th ASH Annual Meeting in San Diego, CA.
Peripheral Immune Profile and MRD Burden Following ASCT in Myeloma
